Spain · Delayed Price · Currency is EUR BME:ACS Statistics
Total Valuation
BME:ACS has a market cap or net worth of EUR 25.12 billion. The enterprise value is 25.89 billion.
| Market Cap | 25.12B |
| Enterprise Value | 25.89B |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
BME:ACS has 265.94 million shares outstanding. The number of shares has increased by 1.97% in one year.
| Current Share Class | 265.94M |
| Shares Outstanding | 265.94M |
| Shares Change (YoY) | +1.97% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 18.21% |
| Float | 188.11M |
Valuation Ratios
The trailing PE ratio is 24.35 and the forward PE ratio is 20.60. BME:ACS's PEG ratio is 1.17.
| PE Ratio | 24.35 |
| Forward PE | 20.60 |
| PS Ratio | 0.48 |
| PB Ratio | 3.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.09 |
| P/OCF Ratio | 7.83 |
| PEG Ratio | 1.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.09, with an EV/FCF ratio of 10.40.
| EV / Earnings | 25.63 |
| EV / Sales | 0.50 |
| EV / EBITDA | 9.09 |
| EV / EBIT | 13.55 |
| EV / FCF | 10.40 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 2.57.
| Current Ratio | 1.25 |
| Quick Ratio | 1.12 |
| Debt / Equity | 2.57 |
| Debt / EBITDA | 6.19 |
| Debt / FCF | 6.55 |
| Interest Coverage | 2.26 |
Financial Efficiency
Return on equity (ROE) is 24.08% and return on invested capital (ROIC) is 15.46%.
| Return on Equity (ROE) | 24.08% |
| Return on Assets (ROA) | 2.32% |
| Return on Invested Capital (ROIC) | 15.46% |
| Return on Capital Employed (ROCE) | 7.33% |
| Weighted Average Cost of Capital (WACC) | 5.99% |
| Revenue Per Employee | 340,845 |
| Profits Per Employee | 6,634 |
| Employee Count | 152,300 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 35.38 |
Taxes
In the past 12 months, BME:ACS has paid 566.33 million in taxes.
| Income Tax | 566.33M |
| Effective Tax Rate | 30.41% |
Stock Price Statistics
The stock price has increased by +37.75% in the last 52 weeks. The beta is 0.64, so BME:ACS's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +37.75% |
| 50-Day Moving Average | 101.49 |
| 200-Day Moving Average | 109.74 |
| Relative Strength Index (RSI) | 48.47 |
| Average Volume (20 Days) | 494,593 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:ACS had revenue of EUR 51.91 billion and earned 1.01 billion in profits. Earnings per share was 3.88.
| Revenue | 51.91B |
| Gross Profit | 15.95B |
| Operating Income | 1.69B |
| Pretax Income | 1.86B |
| Net Income | 1.01B |
| EBITDA | 2.32B |
| EBIT | 1.69B |
| Earnings Per Share (EPS) | 3.88 |
Balance Sheet
The company has 15.83 billion in cash and 16.30 billion in debt, with a net cash position of -466.87 million or -1.76 per share.
| Cash & Cash Equivalents | 15.83B |
| Total Debt | 16.30B |
| Net Cash | -466.87M |
| Net Cash Per Share | -1.76 |
| Equity (Book Value) | 6.35B |
| Book Value Per Share | 22.72 |
| Working Capital | 6.68B |
Cash Flow
In the last 12 months, operating cash flow was 3.21 billion and capital expenditures -720.06 million, giving a free cash flow of 2.49 billion.
| Operating Cash Flow | 3.21B |
| Capital Expenditures | -720.06M |
| Depreciation & Amortization | 627.26M |
| Net Borrowing | 1.26B |
| Free Cash Flow | 2.49B |
| FCF Per Share | 9.36 |
Margins
Gross margin is 30.72%, with operating and profit margins of 3.26% and 1.95%.
| Gross Margin | 30.72% |
| Operating Margin | 3.26% |
| Pretax Margin | 3.59% |
| Profit Margin | 1.95% |
| EBITDA Margin | 4.47% |
| EBIT Margin | 3.26% |
| FCF Margin | 4.79% |
Dividends & Yields
This stock pays an annual dividend of 2.32, which amounts to a dividend yield of 2.42%.
| Dividend Per Share | 2.32 |
| Dividend Yield | 2.42% |
| Dividend Growth (YoY) | 15.51% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 40.37% |
| FCF Payout Ratio | 20.95% |
| Buyback Yield | -1.97% |
| Shareholder Yield | 0.49% |
| Earnings Yield | 4.02% |
| FCF Yield | 9.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:ACS is 134.71, which is 40.10% higher than the current price. The consensus rating is "Buy".
| Price Target | 134.71 |
| Price Target Difference | 40.10% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 9.94% |
| EPS Growth Forecast (3Y) | 19.40% |
Stock Splits
The last stock split was on June 10, 2004. It was a forward split with a ratio of 3.000003.
| Last Split Date | Jun 10, 2004 |
| Split Type | Forward |
| Split Ratio | 3.000003 |
Scores
BME:ACS has an Altman Z-Score of 1.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 5 |